KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Total Non-Current Liabilities (2016 - 2025)

Sarepta Therapeutics has reported Total Non-Current Liabilities over the past 15 years, most recently at $2.2 billion for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $2.2 billion for Q4 2025, down 7.56% from a year ago — trailing twelve months through Dec 2025 was $2.2 billion (down 7.56% YoY), and the annual figure for FY2025 was $2.2 billion, down 7.56%.
  • Total Non-Current Liabilities for Q4 2025 was $2.2 billion at Sarepta Therapeutics, up from $2.2 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for SRPT hit a ceiling of $2.7 billion in Q4 2022 and a floor of $2.1 billion in Q3 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $2.3 billion (2025), compared with a mean of $2.3 billion.
  • Biggest five-year swings in Total Non-Current Liabilities: increased 25.1% in 2022 and later decreased 14.18% in 2023.
  • Sarepta Therapeutics' Total Non-Current Liabilities stood at $2.2 billion in 2021, then grew by 24.36% to $2.7 billion in 2022, then fell by 12.54% to $2.4 billion in 2023, then increased by 0.88% to $2.4 billion in 2024, then dropped by 7.56% to $2.2 billion in 2025.
  • The last three reported values for Total Non-Current Liabilities were $2.2 billion (Q4 2025), $2.2 billion (Q3 2025), and $2.3 billion (Q2 2025) per Business Quant data.